Boundless Bio owners buy 149,474 common shares
The reported purchases were indirect, and Kevin Tang’s footnoted pecuniary interest relates to shares beneficially held by four Tang Capital entities.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Boundless Bio, Inc. ten-percent owners Kevin Tang and Tang Capital Management LLC reported four indirect purchases totaling 149,474 common shares from October 16 through October 20, 2026. The entries were 118,185 shares on October 16 at a weighted-average $2.34 per share; 12,790 shares on October 19 at $2.34; 18,279 shares that day at $2.33; and 220 shares on October 20 at $2.37. Footnotes give the respective transaction price ranges as $2.31–$2.35, $2.31–$2.35, $2.32–$2.35, and $2.33–$2.40. A footnote identifies Kevin Tang’s pecuniary interest in shares beneficially held by Tang Capital Partners, LP; Tang Capital Partners International, LP; Tang Capital Partners III, Inc.; and Tang Capital Partners IV, Inc. The reporting persons stated they delivered $1,723.10 to Boundless Bio. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F6, F3 | 220 | $2.37 | $521.40 |
| Purchase | Common Stock F1, F4, F3 | 12,790 | $2.34 | $30K |
| Purchase | Common Stock F1, F5, F3 | 18,279 | $2.33 | $43K |
| Purchase | Common Stock F1, F2, F3 | 118,185 | $2.34 | $277K |
Footnotes (6)
- F1. The Reporting Persons have delivered to the Issuer the full amount of the disgorgeable profit arising the purchases reported herein, in the amount of $1,723.10.
- F2. The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $2.31 to $2.35. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the range set forth in Footnotes 2 and 4 through 6.
- F3. Tang Capital Partners, LP ("TCP") beneficially owns 688,494 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 937,213 shares, Tang Capital Partners III, Inc. ("TCP III") beneficially owns 688,487 shares, and Tang Capital Partners IV, Inc. ("TCP IV") beneficially owns 675,915 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III and TCP IV, which are indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI, TCP III and TCP IV.
- F4. These shares were purchased in multiple transactions at prices ranging from $2.31 to $2.35.
- F5. These shares were purchased in multiple transactions at prices ranging from $2.32 to $2.35.
- F6. These shares were purchased in multiple transactions at prices ranging from $2.33 to $2.40.
Key Figures
Key Terms
weighted-average prices financial
pecuniary interest financial
beneficially owns financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much did the BOLD reporting persons deliver to Boundless Bio?
AI-generated analysis. How Rhea-AI works. Not financial advice.